8-K: Aflac Reports Solid Q4 Earnings, Reaffirms Dividend Increase

Aflac Incorporated announced its fourth quarter results, reporting net earnings of $268 million and reiterating a 19% increase in the first quarter dividend.

Summary

• Aflac's fourth quarter 2023 total revenues were $3.8 billion, a decrease from $3.9 billion in the same period of 2022.
• Net earnings for the quarter were $268 million, or $0.46 per diluted share, compared to $196 million, or $0.31 per diluted share, in the prior year.
• Adjusted earnings for the fourth quarter were $732 million, a 10.4% decrease from $817 million in the fourth quarter of 2022.
• Adjusted earnings per diluted share decreased by 4.6% to $1.25 in the quarter.
• The company experienced a $119 million post-tax loss related to the novation of a reinsurance treaty.
• Net investment losses were $511 million, driven by derivative and foreign currency losses, and an increase in CECL reserves.
• Shareholders' equity was $22.0 billion, or $38.00 per share, at the end of 2023, compared to $20.1 billion, or $32.73 per share, at the end of 2022.
• For the full year 2023, total revenues were $18.7 billion, down 2.3% from $19.1 billion in 2022.
• Full year net earnings were $4.7 billion, or $7.78 per diluted share, compared to $4.4 billion, or $6.93 per diluted share, in 2022.
• Adjusted earnings for the full year were $3.7 billion, or $6.23 per diluted share, compared to $3.6 billion, or $5.67 per diluted share, in 2022.
• Aflac Japan's net earned premiums decreased by 8.5% in yen terms for the quarter, while adjusted net investment income increased by 13.5%.
• Aflac U.S. net earned premiums increased by 1.1% in the fourth quarter, and adjusted net investment income increased by 9.9%.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with some positive aspects like strong capital position and dividend increase, but also negative aspects like decreased revenue and adjusted earnings. The sentiment is cautiously optimistic, reflecting the company's efforts to navigate challenges and pursue growth.

Positives

• Net earnings per diluted share increased significantly year-over-year.
• Shareholders' equity saw a substantial increase.
• Aflac Japan's adjusted net investment income increased by 13.5% in yen terms.
• Aflac U.S. net earned premiums and adjusted net investment income both increased.
• The company declared a 19% increase in the first quarter dividend.
• Aflac repurchased a significant amount of its own stock.
• The company has strong capital and cash flows.
• Aflac has a long track record of dividend increases.
• Aflac Japan's pretax adjusted profit margin increased to 30.4%.

Negatives

• Total revenues decreased in both the fourth quarter and full year 2023.
• Adjusted earnings and adjusted earnings per diluted share decreased in the fourth quarter.
• The company experienced a post-tax loss related to a reinsurance treaty novation.
• Net investment losses were significant, driven by derivatives and foreign currency activities.
• Aflac Japan's net earned premiums decreased by 8.5% in yen terms for the quarter.
• Aflac U.S. pretax adjusted earnings were lower than the previous year.
• The corporate segment recorded a pretax loss of $318 million.

Risks

• The company faces risks from fluctuations in the yen/dollar exchange rate.
• There are risks associated with global capital markets and the economy, including inflation.
• The company is exposed to interest rate risk and potential defaults on investments.
• Aflac's business is concentrated in Japan, which presents a risk.
• There are risks related to the availability of acceptable yen-denominated investments.
• The company faces competitive pressures and must adapt to market trends.
• Catastrophic events could impact the company's operations and financial results.
• There are risks related to the company's ability to attract and retain qualified personnel.
• The company faces risks related to regulatory changes and compliance.

Future Outlook

Aflac expects to reach 67 to 73 billion of sales in Japan by the end of 2026 and aims to exceed $1.8 billion of sales in the U.S. by the end of 2025. The company anticipates continued strength in core margins in Japan and is focused on providing customer value, scaling growth, and realizing efficiency in the U.S. business.

Management Comments

• Aflac delivered very solid earnings for both the quarter and the year.
• We have continued to actively concentrate on numerous initiatives in the U.S. and Japan around new products and distribution strategies to set the stage for future growth.
• I am pleased with our 10.9% sales increase for the year, which reflected improvements through agencies and alliances, including Japan Post, Dai-ichi Life and Daido Life.
• In the U.S., I remain encouraged by the enhanced value we are delivering to our policyholders and the continued improvement in the productivity of our agents and brokers.
• We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.
• We treasure our track record of dividend growth and remain committed to extending it, supported by the strength of our capital and cash flows.
• We intend to continue our balanced approach of investing in growth and driving long-term operating efficiencies while preserving the strength of underlying cash flows.

Industry Context

Aflac's results reflect the broader trends in the insurance industry, including the impact of economic conditions, interest rates, and foreign exchange fluctuations. The company's focus on new products and distribution strategies aligns with the industry's need to adapt to changing customer preferences and market dynamics. The reinsurance transaction and focus on capital management are also common strategies in the insurance sector.

Comparison to Industry Standards

• Aflac's adjusted return on equity (ROE) of 10.7% is within the range of other large insurance companies, but it is important to note that this is an adjusted figure and not a GAAP figure.
• The company's focus on supplemental health insurance products in the U.S. and cancer and medical insurance in Japan positions it well in these specific markets.
• Aflac's persistency rates in Japan (93.4%) are generally higher than those of many U.S. insurance companies, reflecting the different market dynamics.
• The company's investment portfolio is diversified, but the exposure to commercial real estate loans and the associated CECL reserves are a concern, similar to other financial institutions with real estate exposure.
• Aflac's capital ratios, with an SMR above 1,100% in Japan and a combined RBC greater than 650%, are strong compared to regulatory requirements and industry averages.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and share repurchases.
• Policyholders will benefit from the enhanced value and new products.
• Employees will be impacted by the company's focus on growth and efficiency.
• The company's strong capital position provides stability for all stakeholders.
• The company's commitment to corporate social responsibility and sustainability will benefit the broader community.

Next Steps

• The company will continue to focus on new product development and distribution strategies.
• Aflac will continue to monitor and manage its capital position and deploy capital to drive strong risk-adjusted ROE.
• The company will address its financial results and drivers for earnings in 2024 on the earnings call.
• Aflac will continue to build out its reinsurance platform.

Key Dates

Keywords

Aflac, insurance, financial results, earnings, Japan, United States, dividend, reinsurance, investment income, share repurchase, premiums, exchange rates